Petros Pharmaceuticals, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
OTC.Pink
Petros Pharmaceuticals seeks to raise $1.6 million through a securities offering, including common stock, pre-funded warrants, and Series A and B warrants.
OTC.Pink
S-1/A: Petros Pharmaceuticals Announces Offering, Faces Financial Challenges and NASDAQ Delisting Risk
Petros Pharmaceuticals, Inc. is launching a securities offering amidst significant financial challenges, including ongoing losses, a going concern qualification, and a potential delisting from The Nasdaq Capital Market.
OTC.Pink
Petros Pharmaceuticals aims to raise up to $20 million through a unit offering to advance its platform for prescription-to-over-the-counter medication switches.
OTC.Pink
Petros Pharmaceuticals is seeking to raise up to $20 million through a unit offering to advance its proprietary platform aimed at facilitating the switch of prescription drugs to over-the-counter status.
OTC.Pink
Petros Pharmaceuticals is seeking to raise capital through a unit offering to fund its platform development and general corporate purposes, aiming to become a leader in the self-care market.